TheJobsMapCrossPoint Therapeutics jobs and careers
About CrossPoint Therapeutics
CrossPoint Therapeutics is developing next-generation ADCs and bispecific antibodies based on Stealth-Body, its proprietary Fc-inert antibody platform. By minimizing Fc-mediated off-target toxicity, we aim to improve therapeutic margin and expand the potential of antibody therapeutics for difficult-to-treat cancers.
- Founded
- 2022
- Employees
- 1 to 10
- Total funding
- $2.1B
Leadership
The top of CrossPoint Therapeutics's org chart, with how many people report into each leader.
KC
Ki Hwan C.
Chief Technology Officer
Jobs at CrossPoint Therapeutics
No open positions right now. Explore more companies on TheJobsMap.